EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Right ventricular-pulmonary artery coupling for prognostication in acute pulmonary embolism

Mads Dam Lyhne iD, Behnood Bikdeli iD, David Jiménez iD, Christopher Kabrhel iD, David M Dudzinski, Jorge Moisés, José Luis Lobo, Fernando Armestar, Leticia Guirado, Aitor Ballaz, Manuel Monreal, RIETE investigators

European Heart Journal: Acute Cardiovascular Care · 24.12.2024 · 13 (12) · 817-825

DOI: 10.1093/ehjacc/zuae120 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, online erschienen am 24.10.2024. Verfasst von Mads Dam Lyhne und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Pulmonary Embolism, Pulmonary Artery, Ventricular Function, Right. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Acute pulmonary embolism (PE) increases pulmonary pressure and impair right ventricular (RV) function. Echocardiographic investigation can quantify this mismatch as the tricuspid annular plane systolic excursion (TAPSE) to pulmonary arterial systolic pressure (PASP) ratio. The aim of the study was to investigate the prognostic capabilities of TAPSE/PASP ratio in patients with acute PE. Methods and results We utilized the Registro Informatizado Enfermedad TromboEmbolica registry to analyse consecutive haemodynamically stable PE patients. We used multi-variable logistic regression analyses to assess the association between the TAPSE/PASP ratio and 30-day all-cause mortality across the strata of European Society of Cardiology (ESC) risk categories. We included 4478 patients, of whom 1326 (30%) had low-risk, 2425 (54%) intermediate-low risk and 727 (16%) intermediate-high risk PE. Thirty-day mortality rates were 0.7%, 2.3% and 3.4%, respectively. Mean TAPSE/PASP ratio was 0.65 ± 0.29 in low-risk patients, 0.46 ± 0.30 in intermediate-low risk and 0.33 ± 0.19 in intermediate-high risk patients. In multi-variable analyses, there was an inverse association between TAPSE/PASP ratio and 30-day mortality (adjusted OR 1.32 [95% CI 1.14–1.52] per 0.1 decrease in TAPSE/PASP). TAPSE/PASP ratio below optimal cut-points was associated with increased mortality in low- (<0.40, aOR: 5.88; 95% CI: 1.63–21.2), intermediate-low (<0.43, aOR: 2.96; 95% CI: 1.54–5.71) and intermediate-high risk patients (<0.34, aOR: 4.37; 95% CI: 1.27–15.0). TAPSE/PASP <0.44 showed net reclassification improvement of 18.2% (95% CI: 0.61–35.8) vs. RV/LV ratio >1, and 27.7% (95% CI: 10.2–45.1) vs. ESC risk strata.

Conclusion

Decreased TAPSE/PASP ratio was associated with increased mortality. The ratio may aid in clinical decision-making, particularly for intermediate-risk patients for whom the discriminatory capability of the current risk stratification tools is limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismPulmonary ArteryVentricular Function, RightHumansMaleFemalePrognosisAcute DiseaseAgedHeart VentriclesEchocardiographyRegistriesMiddle AgedVentricular Dysfunction, RightSurvival RateRisk Assessment

Stichwörter der Autor:innen

EchocardiographyPulmonary pressureRight ventricular functionRisk stratificationTAPSE

Autor:innen und Institutionen

  • Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, MA, USA.
  • Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, MA, USA.
  • YNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, CT, USA.
  • Cardiovascular Research Foundation (CRF), New York, NY, USA.

ORCID-Profile: Mads Dam Lyhne, Behnood Bikdeli, David Jiménez, Christopher Kabrhel

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Lyhne, M. D., Bikdeli, B., Jiménez, D., Kabrhel, C., Dudzinski, D. M., Moisés, J., Lobo, J. L., Armestar, F., Guirado, L., Ballaz, A., Monreal, M., & RIETE investigators (2024). Right ventricular-pulmonary artery coupling for prognostication in acute pulmonary embolism. European Heart Journal: Acute Cardiovascular Care, 13(12), 817-825. https://doi.org/10.1093/ehjacc/zuae120

Vancouver

Lyhne MD, Bikdeli B, Jiménez D, Kabrhel C, Dudzinski DM, Moisés J, et al. Right ventricular-pulmonary artery coupling for prognostication in acute pulmonary embolism. European Heart Journal: Acute Cardiovascular Care. 2024;13(12):817-825. doi:10.1093/ehjacc/zuae120

BibTeX
@article{Lyhne2024,
  author = {Lyhne, Mads Dam and Bikdeli, Behnood and Jiménez, David and Kabrhel, Christopher and Dudzinski, David M and Moisés, Jorge and Lobo, José Luis and Armestar, Fernando and Guirado, Leticia and Ballaz, Aitor and Monreal, Manuel and RIETE investigators, RIETE investigators},
  title = {Right ventricular-pulmonary artery coupling for prognostication in acute pulmonary embolism},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2024},
  volume = {13},
  number = {12},
  pages = {817--825},
  doi = {10.1093/ehjacc/zuae120}
}
Kostenlos starten →